Treatments for Squamous Cell Cancer
Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an...
Wedi'i Gadw mewn:
| Fformat: | Online |
|---|---|
| Iaith: | Saesneg |
| Cyhoeddwyd: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Pynciau: | |
| Mynediad Ar-lein: | ONIX_20230220_9783036547589_15 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
| _version_ | 1869523017547120640 |
|---|---|
| collection | Directory of Open Access Books |
| description | Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes. |
| format | Online |
| id | doab-20.500.12854ir-97412 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-974122024-03-31T22:43:29Z Treatments for Squamous Cell Cancer Darido, Charbel n/a oral cancer tobacco alcohol human papilloma virus targeted sequencing DNA copy number TP53 CDKN2A EGFR PIK3CA anal cancer radiation therapy chemoradiation de-escalation of therapy pain cathepsin S protease-activated receptor-2 PAR2 cancer pain oral squamous cell carcinoma differentiation terminal differentiation oral epithelium epithelial integrity epithelial transformation genetic alterations therapy response biomarkers cutaneous squamous cell carcinoma immunotherapy anti-PD1 biomarkers predictive medicine personalized medicine cancer immune system HNSCC farnesyl transferase tipifarnib combination regimen oropharynx neoplasm squamous cell carcinoma human papillomavirus therapeutic management treatment selection CSCC treatment advances biology immunocompromised immune checkpoint inhibition thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes. 2023-02-20T16:43:14Z 2023-02-20T16:43:14Z 2022 book ONIX_20230220_9783036547589_15 9783036547589 9783036547572 https://directory.doabooks.org/handle/20.500.12854/97412 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/5974 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-4757-2 10.3390/books978-3-0365-4757-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036547589 9783036547572 168 Basel open access |
| spellingShingle | n/a oral cancer tobacco alcohol human papilloma virus targeted sequencing DNA copy number TP53 CDKN2A EGFR PIK3CA anal cancer radiation therapy chemoradiation de-escalation of therapy pain cathepsin S protease-activated receptor-2 PAR2 cancer pain oral squamous cell carcinoma differentiation terminal differentiation oral epithelium epithelial integrity epithelial transformation genetic alterations therapy response biomarkers cutaneous squamous cell carcinoma immunotherapy anti-PD1 biomarkers predictive medicine personalized medicine cancer immune system HNSCC farnesyl transferase tipifarnib combination regimen oropharynx neoplasm squamous cell carcinoma human papillomavirus therapeutic management treatment selection CSCC treatment advances biology immunocompromised immune checkpoint inhibition thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Treatments for Squamous Cell Cancer |
| title | Treatments for Squamous Cell Cancer |
| title_full | Treatments for Squamous Cell Cancer |
| title_fullStr | Treatments for Squamous Cell Cancer |
| title_full_unstemmed | Treatments for Squamous Cell Cancer |
| title_short | Treatments for Squamous Cell Cancer |
| title_sort | treatments for squamous cell cancer |
| topic | n/a oral cancer tobacco alcohol human papilloma virus targeted sequencing DNA copy number TP53 CDKN2A EGFR PIK3CA anal cancer radiation therapy chemoradiation de-escalation of therapy pain cathepsin S protease-activated receptor-2 PAR2 cancer pain oral squamous cell carcinoma differentiation terminal differentiation oral epithelium epithelial integrity epithelial transformation genetic alterations therapy response biomarkers cutaneous squamous cell carcinoma immunotherapy anti-PD1 biomarkers predictive medicine personalized medicine cancer immune system HNSCC farnesyl transferase tipifarnib combination regimen oropharynx neoplasm squamous cell carcinoma human papillomavirus therapeutic management treatment selection CSCC treatment advances biology immunocompromised immune checkpoint inhibition thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | n/a oral cancer tobacco alcohol human papilloma virus targeted sequencing DNA copy number TP53 CDKN2A EGFR PIK3CA anal cancer radiation therapy chemoradiation de-escalation of therapy pain cathepsin S protease-activated receptor-2 PAR2 cancer pain oral squamous cell carcinoma differentiation terminal differentiation oral epithelium epithelial integrity epithelial transformation genetic alterations therapy response biomarkers cutaneous squamous cell carcinoma immunotherapy anti-PD1 biomarkers predictive medicine personalized medicine cancer immune system HNSCC farnesyl transferase tipifarnib combination regimen oropharynx neoplasm squamous cell carcinoma human papillomavirus therapeutic management treatment selection CSCC treatment advances biology immunocompromised immune checkpoint inhibition thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230220_9783036547589_15 |